Vanguard Group
CARM icon

Vanguard Group’s Carisma Therapeutics CARM Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$137K Sell
350,324
-1,045,284
-75% -$410K ﹤0.01% 4118
2025
Q1
$433K Sell
1,395,608
-23,240
-2% -$7.2K ﹤0.01% 3919
2024
Q4
$594K Sell
1,418,848
-29,399
-2% -$12.3K ﹤0.01% 3893
2024
Q3
$1.42M Hold
1,448,247
﹤0.01% 3665
2024
Q2
$2.2M Sell
1,448,247
-131,714
-8% -$200K ﹤0.01% 3527
2024
Q1
$3.59M Buy
1,579,961
+11,200
+0.7% +$25.4K ﹤0.01% 3418
2023
Q4
$4.6M Buy
1,568,761
+8,435
+0.5% +$24.7K ﹤0.01% 3324
2023
Q3
$6.6M Buy
1,560,326
+50,864
+3% +$215K ﹤0.01% 3123
2023
Q2
$13.2M Buy
1,509,462
+943,743
+167% +$8.28M ﹤0.01% 2792
2023
Q1
$1.75M Sell
565,719
-10,288,581
-95% -$31.9M ﹤0.01% 3726
2022
Q4
$6.62M Buy
10,854,300
+4,237
+0% +$2.58K ﹤0.01% 3159
2022
Q3
$4.61M Buy
10,850,063
+107,690
+1% +$45.8K ﹤0.01% 3373
2022
Q2
$8.71M Sell
10,742,373
-1,952,403
-15% -$1.58M ﹤0.01% 3069
2022
Q1
$7.65M Buy
12,694,776
+328,020
+3% +$198K ﹤0.01% 3292
2021
Q4
$10.1M Buy
12,366,756
+2,163,226
+21% +$1.76M ﹤0.01% 3199
2021
Q3
$8.09M Buy
10,203,530
+1,699,548
+20% +$1.35M ﹤0.01% 3371
2021
Q2
$39.3M Buy
8,503,982
+1,308,430
+18% +$6.05M ﹤0.01% 2494
2021
Q1
$18.7M Buy
7,195,552
+1,301,932
+22% +$3.38M ﹤0.01% 2821
2020
Q4
$7.96M Buy
5,893,620
+1,193,485
+25% +$1.61M ﹤0.01% 3110
2020
Q3
$6.58M Buy
4,700,135
+698,910
+17% +$978K ﹤0.01% 3011
2020
Q2
$2.88M Sell
4,001,225
-599
-0% -$431 ﹤0.01% 3322
2020
Q1
$2.24M Hold
4,001,824
﹤0.01% 3270
2019
Q4
$4.16M Buy
4,001,824
+166,543
+4% +$173K ﹤0.01% 3225
2019
Q3
$4.49M Buy
3,835,281
+280,718
+8% +$328K ﹤0.01% 3175
2019
Q2
$5.33M Buy
3,554,563
+22,228
+0.6% +$33.3K ﹤0.01% 3142
2019
Q1
$3.64M Buy
3,532,335
+833,833
+31% +$859K ﹤0.01% 3256
2018
Q4
$3.83M Buy
2,698,502
+179,611
+7% +$255K ﹤0.01% 3173
2018
Q3
$5.42M Buy
2,518,891
+454,950
+22% +$978K ﹤0.01% 3204
2018
Q2
$4.03M Buy
2,063,941
+1,626,831
+372% +$3.17M ﹤0.01% 3281
2018
Q1
$459K Buy
437,110
+110,227
+34% +$116K ﹤0.01% 3802
2017
Q4
$265K Buy
326,883
+142,579
+77% +$116K ﹤0.01% 3879
2017
Q3
$291K Sell
184,304
-22,146
-11% -$35K ﹤0.01% 3846
2017
Q2
$324K Buy
206,450
+30,600
+17% +$48K ﹤0.01% 3804
2017
Q1
$386K Buy
175,850
+54,694
+45% +$120K ﹤0.01% 3798
2016
Q4
$231K Buy
121,156
+7,500
+7% +$14.3K ﹤0.01% 3866
2016
Q3
$319K Buy
113,656
+36,000
+46% +$101K ﹤0.01% 3829
2016
Q2
$130K Hold
77,656
﹤0.01% 3997
2016
Q1
$25K Sell
77,656
-126,551
-62% -$40.7K ﹤0.01% 4114
2015
Q4
$614K Buy
204,207
+12,431
+6% +$37.4K ﹤0.01% 3776
2015
Q3
$462K Buy
191,776
+79,044
+70% +$190K ﹤0.01% 3870
2015
Q2
$318K Buy
112,732
+10,925
+11% +$30.8K ﹤0.01% 3970
2015
Q1
$908K Buy
101,807
+6,750
+7% +$60.2K ﹤0.01% 3658
2014
Q4
$1.13M Buy
95,057
+575
+0.6% +$6.84K ﹤0.01% 3493
2014
Q3
$1.05M Buy
94,482
+8,020
+9% +$89.3K ﹤0.01% 3490
2014
Q2
$1.14M Sell
86,462
-425
-0.5% -$5.6K ﹤0.01% 3455
2014
Q1
$1.41M Buy
+86,887
New +$1.41M ﹤0.01% 3346